$200.97B
Revenue
$60.46B
Net Income
82.00%
Gross Margin
41.44%
Op. Margin
$77.30B
Free Cash Flow
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Total Revenue | $200.97B | $200.97B | $164.50B | $134.90B | $116.61B | $117.93B |
| Revenue Growth % | -0.0% | 22.2% | 21.9% | 15.7% | -1.1% | nan% |
| Cost of Revenue | $36.17B | $36.17B | $30.16B | $25.96B | $25.25B | $22.65B |
| Gross Profit | $164.79B | $164.79B | $134.34B | $108.94B | $91.36B | $95.28B |
| Gross Margin % | 82.0% | 82.0% | 81.7% | 80.8% | 78.3% | 80.8% |
| Operating Expenses | $117.69B | $117.69B | $95.12B | $88.15B | $87.67B | $71.18B |
| Research & Development | $57.37B | $57.37B | $43.87B | $38.48B | $35.34B | $24.66B |
| Operating Income | $83.28B | $83.28B | $69.38B | $46.75B | $28.94B | $46.75B |
| Operating Margin % | 41.4% | 41.4% | 42.2% | 34.7% | 24.8% | 39.6% |
| Interest Expense | $1.92B | $1.09B | $683.00M | $420.00M | - | - |
| Interest Income | - | $2.12B | $2.52B | $1.64B | - | - |
| Other Income/Expense | $1.35B | $1.35B | $171.00M | $-150.00M | $-125.00M | $531.00M |
| Income Before Tax | $85.93B | $85.93B | $70.66B | $47.43B | $28.82B | $47.28B |
| Income Tax Expense | $25.48B | $25.47B | $8.30B | $8.33B | $5.62B | $7.91B |
| Net Income | $60.46B | $60.46B | $62.36B | $39.10B | $23.20B | $39.37B |
| Net Margin % | 30.1% | 30.1% | 37.9% | 29.0% | 19.9% | 33.4% |
| Basic EPS | nan | 23.98 | 24.61 | 15.19 | 8.63 | 13.99 |
| Diluted EPS | nan | 23.49 | 23.86 | 14.87 | 8.59 | 13.77 |
| Basic Shares Outstanding | 1.0M | 2.52B | 2.53B | 2.57B | 2.69B | 2.81B |
| Diluted Shares Outstanding | -4.0M | 2.57B | 2.61B | 2.63B | 2.70B | 2.86B |
| Breakdown | FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $35.87B | $43.89B | $41.86B | $14.68B | $16.60B |
| Short-term Investments | $45.72B | $33.93B | $23.54B | $26.06B | $31.40B |
| Accounts Receivable | $19.77B | $16.99B | $16.17B | $13.47B | $14.04B |
| Other Current Assets | $7.36B | $5.24B | $3.79B | $5.34B | $4.63B |
| Total Current Assets | $108.72B | $100.05B | $85.36B | $59.55B | $66.67B |
| Goodwill | $24.53B | $20.65B | $20.65B | $20.31B | $19.20B |
| Intangible Assets | $3.69B | $915.00M | $788.00M | $897.00M | $634.00M |
| Other Non-current Assets | $8.44B | $13.02B | $6.79B | $6.58B | $2.75B |
| Total Assets | $366.02B | $276.05B | $229.62B | $185.73B | $165.99B |
| Accrued Liabilities | $30.73B | $23.97B | $24.62B | $19.55B | $14.31B |
| Total Current Liabilities | $41.84B | $33.60B | $31.96B | $27.03B | $21.14B |
| Long-term Debt | $58.74B | $28.83B | $18.39B | $9.92B | - |
| Other Non-current Liabilities | $4.25B | $2.72B | $8.88B | $7.76B | $7.23B |
| Total Liabilities | $148.78B | $93.42B | $76.45B | $60.01B | $41.11B |
| Common Stock | - | - | - | - | - |
| Retained Earnings | $121.18B | $102.51B | $82.07B | $64.80B | $69.76B |
| Total Stockholders Equity | $217.24B | $182.64B | $153.17B | $125.71B | $124.88B |
| Total Liabilities & Equity | $366.02B | $276.05B | $229.62B | $185.73B | $165.99B |
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Net Income | $77.10B | $60.46B | $62.36B | $39.10B | $23.20B | $39.37B |
| Depreciation & Amortization | $30.76B | $18.62B | $15.50B | $11.18B | $8.69B | $7.97B |
| Stock-based Compensation | $33.55B | $20.43B | $16.69B | $14.03B | $11.99B | $9.16B |
| Deferred Income Tax | $15.60B | $18.75B | $-4.74B | $131.00M | $-3.29B | $609.00M |
| Change in Receivables | $-2.46B | $1.81B | $1.49B | $2.40B | $-231.00M | $3.11B |
| Operating Cash Flow | $189.41B | $115.80B | $91.33B | $71.11B | $50.48B | $57.68B |
| Capital Expenditure | $112.11B | $69.69B | $37.26B | $27.27B | $31.43B | $18.57B |
| Purchases of Investments | - | $36.93B | $25.54B | $2.98B | $9.63B | - |
| Sales of Investments | - | - | - | - | $2.08B | $10.91B |
| Investing Cash Flow | $-167.98B | $-102.00B | $-47.15B | $-24.50B | $-28.97B | $-7.57B |
| Stock Repurchased | $61.92B | $26.25B | $30.12B | $19.77B | $27.96B | $44.54B |
| Dividends Paid | $5.32B | $5.32B | $5.07B | - | - | - |
| Financing Cash Flow | $-75.34B | $-20.37B | $-40.78B | $-19.50B | $-22.14B | $-50.73B |
| Net Change in Cash | $-53.31B | $-6.34B | $2.61B | $27.23B | $-1.27B | $-1.09B |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $51.24B | $40.59B | $141.07B | $116.12B |
| Cost of Revenue | $9.21B | $7.38B | $25.27B | $21.32B |
| Operating Expenses | $30.71B | $23.24B | $82.54B | $70.10B |
| Research & Development | $15.14B | $11.18B | $40.24B | $31.69B |
| Operating Income | $20.54B | $17.35B | $58.53B | $46.02B |
| Interest Expense | - | - | $603.00M | $356.00M |
| Other Income/Expense | $1.13B | $472.00M | $2.05B | $1.09B |
| Income Before Tax | $21.66B | $17.82B | $60.58B | $47.11B |
| Income Tax Expense | $18.95B | $2.13B | $22.89B | $5.59B |
| Net Income | $2.71B | $15.69B | $37.69B | $41.52B |
| Basic EPS | 1.08 | 6.20 | 14.96 | 16.37 |
| Diluted EPS | 1.05 | 6.03 | 14.62 | 15.88 |
| Basic Shares Outstanding | $2.52B | $2.53B | $2.52B | $2.54B |
| Diluted Shares Outstanding | $2.57B | $2.60B | $2.58B | $2.62B |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $10.19B | $43.89B |
| Short-term Investments | $34.26B | $33.93B |
| Accounts Receivable | $17.30B | $16.99B |
| Other Current Assets | $11.37B | $5.24B |
| Total Current Assets | $73.12B | $100.05B |
| Goodwill | $21.16B | $20.65B |
| Other Non-current Assets | $6.85B | $13.02B |
| Total Assets | $303.84B | $276.05B |
| Accrued Liabilities | $27.05B | $23.97B |
| Total Current Liabilities | $36.96B | $33.60B |
| Long-term Debt | $28.83B | $28.83B |
| Other Non-current Liabilities | $12.13B | $2.72B |
| Total Liabilities | $109.78B | $93.42B |
| Common Stock | - | - |
| Retained Earnings | $101.58B | $102.51B |
| Total Stockholders Equity | $194.07B | $182.64B |
| Total Liabilities & Equity | $303.84B | $276.05B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $2.71B | $15.69B | $37.69B | $41.52B |
| Depreciation & Amortization | - | - | $13.21B | $11.04B |
| Stock-based Compensation | - | - | $14.54B | $12.43B |
| Deferred Income Tax | - | - | $17.70B | $-3.41B |
| Change in Receivables | - | - | $-660.00M | $-1.49B |
| Operating Cash Flow | - | - | $79.59B | $63.34B |
| Capital Expenditure | - | - | $48.31B | $22.83B |
| Investing Cash Flow | - | - | $-67.82B | $-25.65B |
| Stock Repurchased | - | - | $26.25B | $30.12B |
| Dividends Paid | $1.33B | $1.26B | $3.99B | $3.80B |
| Financing Cash Flow | - | - | $-45.52B | $-35.32B |
| Net Change in Cash | - | - | $-33.50B | $2.30B |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.